// App-Quantinova.ai

: Comparing characteristics of patients (pts) with CKD and hyperkalemia (HK) with and without a diagnostic (Dx) code for HK: a report from the DISCOVER CKD retrospective cohort

Researchers

Presenter

  • C Pollock

Principal Investigators

  • G James

  • JJ Carrero

  • M Khezrian

  • S Fishbane

  • H Chen

  • E Kanda

  • K Järbrink

  • CSP Lam

  • M Lainscak

  • P Stenvinkel

  • DC Wheeler

  • R Pecoits-Filho

Medical Centers

  • Arbor Research Collaborative for Health, Ann Arbor, MI

  • Royal North Shore Hospital/ University of Sydney, St Leonards, Australia

  • Kings College London, London, United Kingdom

  • Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY

  • Karolinska Institutet, Stockholm, Sweden

  • Karolinska University Hospital, Stockholm, Sweden

  • Pontificia Universidade Catolica do Parana (PUC-PR), Curitiba, Brazil

  • AstraZeneca, Gaithersberg, MD, United States,

  • AstraZeneca, Molndal, Sweden

  • University of Ljubljana, Ljubljana, Slovenia

  • Astra Zeneca, Cambridge, United Kingdom

  • Kawasaki Medcl Scholl, Kurashiki, Japan

  • National Heart Centre Singapore, Singapore, NC

  • National University Hospital Singapore, Singapore, Singapore

Locations

  • Japan

  • Sweden

  • United Kingdom

  • Slovenia

  • United States

  • Brazil

  • Singapore

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Nephrology

Disease

  • Non-dialysis-dependent chronic kidney disease

  • Hyperkalemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved